Martínez-Medina MÁ, Pérez-Jacinto AA

Language: Spanish
References: 21
Page: 92-98
PDF size: 208.23 Kb.

ABSTRACT

The damage to the vascular permeability produced in the Mountain Spotted Fever for Rickettsia Rickettsii (FMRR) leads to a severe shock state, which must be corrected quickly. However, fluid overload is indicated as a risk of adverse outcomes. The objective was to find the possible relationship between the fluids administered at the patient’s admission and the lethality of the disease. Material and Methods: Twenty-eight children with FMRR were studied. The clinical variables and laboratory results were obtained from the record of each patient. The FMRR was classified according to its severity. In addition, the amount of fluids administered in the first 24 hours of treatment was obtained. The study group was divided into fatal and non-fatal cases. Results: The mean volume of fluids administered per ml / m2sc / day in non-fatal cases was 1,833 ± 708 and in deceased patients 4,056 ± 168 (P = 0.000). As for the group of serious patients, the nonfatal patients received a total of 1,746 ± 741ml / m2sc / day and the fatal ones were 4,362 ± 1,616 m2sc / day (P ‹0.017). Conclusion: Fluid administration during the first 24 hours of admission in fatal cases was significantly greater than that given to nonfatal patients. Fluid overload can contribute to the risk of death in severe cases of FMRR.

REFERENCES

1. Martínez-Medina M, Padilla-Zamudio G, Solís-Gallardo L, Guevara-Tovar M. Fiebre manchada de las montañas rocosas. Informe de dos casos. Gac Méd Méx, 2005; 141 (4): 309-312.

2. Martínez-Medina M, Álvarez Hernández G, Padilla- Zamudio G, Rojas-Guerra. Fiebre Manchada de las Montañas Rocosas en niños: consideraciones clínicas y epidemiológicas. Gac Méd Méx, 2007; 143 (2): 137-140.

3. Álvarez-Hernández, Murillo-Benítez, Candia-Plata, Moro M. Clinical profile and predictors of fatal Rocky Mountain spotted fever in children from Sonora, Mexico. Pediatric Infect Dis J, 2015: 34 (2): 125-130.

4. Harrel GT, Venning W. The treatment of Rocky Mountain spotted fever: with particular, reference to intravenous fluids a new approach to basic supportive therapy. JAMA, 1944; 126 (15): 929-934.

5. Ong H, Raffetto JF. Rocky Mountain spotted fever. An analysis of eighteen cases in children. J Pediatr, 1940; 17 (5): 647-653.

6. Liu CT, Hilmas DE, Griffin MJ, Pedersen CE, Haddick CL, Beisbel WR. Alterations of body fluid compartments and distribution of tissue water and electrolytes in Rhesus monkeys wit Rocky Mountain spotted fever. J Infect Dis, 1978; 138: 42-8.

7. Álvarez-Hernández G. La fiebre manchada de las Montañas Rocosas, una epidemia olvidada. Salud Púb Méx, 2010; 52 (1): 1-2.

8. Álvarez-Hernández G, Candia-Plata MC, Delgado- De la Mora J, Acuña-Meléndrez N, Vargas-Ortega A, Licona-Enríquez J. Rocky Mountain spotted fever in Mexican children: Clinical and mortality factors. Salud Púb Mex, 2016; 58 (3): 385-392.

9. Harrell GT, Aikawa JK. Pathogenesis of circulatory failure in Rocky Mountain spotted fever. Arch Intern Med, 1949; 83: 331-347.

10. Álvarez-Hernández G, Murillo-Benítez C, Candia- Plata MC, Moro M. Clinical profile and predictors of fatal Rocky Mountain spotted fever in children from Sonora, Mexico. Pediatr Infect Dis J, 2015; 34: 125-130.

11. Herbert L. Dupont, Larry K. Pickering. Human Rickettsioses. En: Pediatrics. Abraham M. Rudolph, Julien I.E. Hoffman (eds), 17a edition. Norwalk, Connecticut: Appleton-Century-Crofts, 1982; 640-646.

12. Ralph Feigin, Marc L. Boom. Rickettsial Diseases. En: Oski´s Pediatrics, Principles and Practice. Julia A. McMillan, Catherine D. Deangelis, Ralph D. Feigin, Joseph B. Warshaw (eds), Third ed. Philadelphia, PA. Lippincott Williams and Wilkins, 1999; 898-908.

13. Buckingham SC, Marshall GS, Schutze GE, Woods CR, Jackson MA, Patterson LE, et al. Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children. J Pediatr, 2007 Feb; 150 (2): 180-4, 184.e1.

14. Delgado-De la Mora J, Licona-Enríquez JD, Leyva- Gastélum M, Delgado-De la Mora D, Rascón-Alcántar A, Álvarez-Hernández G. A fatal case series of Rocky Mountain spotted fever in Sonora, México. Biomédica, 2018; 38 (1): 69-76.

15. Martínez-Medina MÁ, Rascón-Alcántar A. Complications and cause of death in mexican children with Rocky Mountain spotted fever. 2016; 152 (6): 789-795.

16. Feigin RD, Kissane JM, Eisenberg CS, Kahn LI. Rocky Mountain spotted fever. Successful application of new insights into physiologic changes during acute infections to successful management of a severely ill patient. Clin Pediatr (Phila), 1969; 8 (6): 331-43.

17. Maitland K, Kiguli S, Opoka R, Engoru CH, Olupot OP, Akech S, et al. Mortality after fluid bolus in african children with severe infection. N Engl J Med, 2011; 364 (26): 2483-95.

18. Maitland K, George EC, Evans JA, Kiguli S, Olupot PO, Akech S, et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Medicine, 2013; 11: 68.

19. Davis AL, Carcillo JA, Aneja RK, Deymann AJ, Lin JC, Nguyen TC. American College of Critical Care Medicine. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock. Crit Care Med, 2017; 45 (6): 1061-1092.

20. World Health Organization. (2016). Updated guideline: pediatric emergency triage, assessment and treatment: care of critically-ill children. World Health Organization [Internet]. 2018 (consultado 16 de agosto). URL disponible en: http://www.who.int/iris/handle/10665/204463

21. Malbrain ML, Van Regenmortel N, Saugel B, De Tavernier B, Van Gaal PJ, Joannes‑Boyau O. Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapy. Ann Intensive Care, 2018; 8: 66.